Comparison of Voriconazole Concentration in the Aqueous Humor and Vitreous between Non-Scraped and Scraped Corneal Epithelium Groups after Topical 1% Voriconazole Application
- 2 July 2010
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 35 (7), 573-579
- https://doi.org/10.3109/02713681003760135
Abstract
To investigate the penetration of topical 1% voriconazole through the cornea into the aqueous humor in New Zealand white rabbits and to determine the effect of mechanical scraping of the corneal epithelium. The right eyes of 29 New Zealand white rabbits were maintained with the epithelium intact, and the left eyes underwent mechanical epithelium debridement of the central 7.5 mm of the cornea. A loading dose consisted of a drop of 1% voriconazole applied every 5 min for the initial half hour and followed by a maintenance dose consisting of a drop every 20 min, which was applied for about 2 hr. Then, the first sample was obtained 5 min after the first seven doses (loading dose) were given, and then four more samples were taken 5 min after four more subsequent drops (maintenance dose). The samples were analyzed by high performance liquid chromatography. The mean aqueous concentration of voriconazole was 33.44 +/- 5.77 microg/mL 5 min after the loading dose in the non-scraped group and 57.67 +/- 6.77 microg/mL in the scraped group, respectively. The mean aqueous concentration of voriconazole was maintained in a range from 19.97 to 23.70 microg/mL 5 min after the maintenance doses in the non-scraped group and from 44.44 to 49.02 microg/ mL in the scraped group. The mean vitreous concentration of voriconazole ranged from 0.38 to 0.49 microg/mL in the non-scraped group and ranged from 0.72 to 0.94 microg/mL in the scraped group. These levels were statistically significant (P < 0.05) between the scraped and non-scraped groups. Topically administered voriconazole achieved minimum inhibitory concentrations in the aqueous for all the organisms most commonly involved in fungal endophthalmitis and achieved minimum inhibitory concentrations in the vitreous for some pathogenic fungi. The concentrations of voriconazole were higher in the scraped group than in the non-scraped group.Keywords
This publication has 29 references indexed in Scilit:
- Exogenous Fungal Endophthalmitis: Microbiology and Clinical OutcomesOphthalmology, 2008
- Efficacy of Intracameral Amphotericin B Injection in the Management of Refractory Keratomycosis and EndophthalmitisCornea, 2007
- Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in HumansArchives of Ophthalmology (1950), 2004
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000Antimicrobial Agents and Chemotherapy, 2002
- Voriconazole: A New Triazole AntifungalAnnals of Pharmacotherapy, 2000
- The Changing Spectrum of Fungal Keratitis in South FloridaOphthalmology, 1994
- Epidemiologic Characteristics, Predisposing Factors, and Etiologic Diagnosis of Corneal Ulceration in NepalAmerican Journal of Ophthalmology, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Exogenous Fungal EndophthalmitisOphthalmology, 1988